These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 11371878)
1. Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. Waidelich R; Stepp H; Baumgartner R; Weninger E; Hofstetter A; Kriegmair M J Urol; 2001 Jun; 165(6 Pt 1):1904-7. PubMed ID: 11371878 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy. Lee JY; Diaz RR; Cho KS; Lim MS; Chung JS; Kim WT; Ham WS; Choi YD J Urol; 2013 Oct; 190(4):1192-9. PubMed ID: 23648222 [TBL] [Abstract][Full Text] [Related]
3. Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source. Waidelich R; Beyer W; Knüchel R; Stepp H; Baumgartner R; Schröder J; Hofstetter A; Kriegmair M Urology; 2003 Feb; 61(2):332-7. PubMed ID: 12597941 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study. Berger AP; Steiner H; Stenzl A; Akkad T; Bartsch G; Holtl L Urology; 2003 Feb; 61(2):338-41. PubMed ID: 12597942 [TBL] [Abstract][Full Text] [Related]
5. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors. Waidelich R; Hofstetter A; Stepp H; Baumgartner R; Weninger E; Kriegmair M J Urol; 1998 Feb; 159(2):401-4. PubMed ID: 9649248 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. Nseyo UO; Shumaker B; Klein EA; Sutherland K J Urol; 1998 Jul; 160(1):39-44. PubMed ID: 9628601 [TBL] [Abstract][Full Text] [Related]
7. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group. Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805 [TBL] [Abstract][Full Text] [Related]
8. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic applications in superficial bladder cancer: facts and hopes! Jichlinski P J Environ Pathol Toxicol Oncol; 2006; 25(1-2):441-51. PubMed ID: 16566734 [TBL] [Abstract][Full Text] [Related]
15. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra. Taylor JH; Davis J; Schellhammer P Clin Genitourin Cancer; 2007 Sep; 5(6):386-9. PubMed ID: 17956711 [TBL] [Abstract][Full Text] [Related]
18. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Itkin A; Gilchrest BA Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801 [TBL] [Abstract][Full Text] [Related]
19. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells. Bachor R; Reich E; Rück A; Hautmann R Urol Res; 1996; 24(5):285-9. PubMed ID: 8931293 [TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]